Toward a better understanding of the etiology of systemic autoimmune diseases : should a systemic disease still be defined as a "diffuse inflammatory disease of unknown origin" in 2021? Example of crystalline silica exposure. Vers une meilleure compréhension de l’étiologie des maladies auto-immunes systémiques : une maladie systémique doit-elle toujours être définie comme une « maladie inflammatoire diffuse d’origine inconnue » en 2021 ? Exemple de l’exposition à la silice cristalline

Archive ouverte

Lescoat, A | Cavalin, Catherine | Lecureur, V | Jégo, P

Edité par CCSD ; Elsevier -

National audience

Suggestions

Du même auteur

Drug-induced granulomatosis is dupilumab the new kid on the block?

Archive ouverte | Belhomme, N | CCSD

International audience. Dupilumab is an IgG4 antibody directed toward IL-4 and IL-13, two major effectors of the Th2 immunity response. It was originally developed for severe and/or refractory atopic dermatitis, nev...

[Hypersensitivity Pneumonitis: An update]

Archive ouverte | Chauvin, P | CCSD

National audience. Hypersensitivity Pneumonitis (HP) is a common immune-mediated interstitial lung disease (ILD) induced by repeated exposure to environmental antigens in susceptible individuals. The most commonly k...

[Systemic sclerosis-related interstitial lung disease: Diagnostic and therapeutic strategy in the light of recent clinical trials]

Archive ouverte | Lescoat, A | CCSD

National audience. Systemic sclerosis (SSc) is an autoimmune disease associated to fibrotic manifestations. Interstitial lung disease (SSc-ILD), one of the main fibrotic features of SSc, is the first cause of SSc-re...

Chargement des enrichissements...